ArticleFrontiers in cellular and infection microbiology2026
Epidemiology of Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, and Ureaplasma urealyticum in males of andrology clinics in Nanjing, China: a 10 years retrospective study.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this single-center, cross-sectional and retrospective study is to assess the prevalence of Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), Neisseria gonorrhoeae (NG), and Ureaplasma urealyticum (UU) among males of the Nanjing Drum Tower Hospital's Andrology Department in Nanjing, China. Methods: In the review, we included male patients who consulted the Nanjing Drum Tower Hospital's Andrology Department between 2016 and 2025. Urine samples were obtained from the patients, and all samples were tested by nucleic acid amplification tests (NAATs) for CT, MG, NG, and UU. Results: This research recruited 58,136 males (mean age: 32.29 ± 5.63 years; age range: 16-76 years). The positive rates for CT, MG, NG, and UU were 2.62%, 2.77%, 0.85%, and 50.16%, respectively. Males aged ≤ 24 years had the highest positive rates for CT (7.30%), MG (4.76%), and NG (4.89%), whereas males between the ages of 25-29 had the highest UU positive rate (53.17%). The single positive rate (93.84%) was significantly more common than mix positive rates (6.16%), alongside the MG+UU mix positive representing the most frequent combination. The ≤24-year age group had significantly more mix-positives than other age groups. Conclusions: Among males of our andrology outpatient clinic, the incidence of UU positive was markedly greater than that of CT, MG, and NG. Single positives were more predominant. Young people aged ≤24 had higher rates of STIs. Our findings contribute to a better understanding of the epidemiology of CT, MG, NG, and UU in our hospital of Nanjing, which allows for the comparison of patients across various geographies and sources, as well as the analysis of potential causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.